Q32 Bio Inc. (QTTB)
(Delayed Data from NSDQ)
$1.95 USD
-0.03 (-1.52%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $1.99 +0.04 (2.05%) 4:22 PM ET
3-Hold of 5 3
F Value D Growth B Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
QTTB 1.95 -0.03(-1.52%)
Will QTTB be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for QTTB based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for QTTB
All You Need to Know About Q32 Bio (QTTB) Rating Upgrade to Buy
Q32 Bio (QTTB) Upgraded to Buy: What Does It Mean for the Stock?
QTTB: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's Why Q32 Bio Stock Hit a New Record Low on Wednesday
Wall Street Analysts Think Q32 Bio (QTTB) Could Surge 91.69%: Read This Before Placing a Bet
Other News for QTTB
Q32 Bio GAAP EPS of -$0.78
Q32 Bio Inc Reports Q2 2025 Net Loss of $0.78 Per Share, Cash Reserves at $54.8 Million
Q32 Bio Reports Second Quarter 2025 Financial Results and Provides Corporate Update | QTTB ...
12 Health Care Stocks Moving In Thursday's Intraday Session
12 Health Care Stocks Moving In Monday's Intraday Session